CATALOGO DEI PRODOTTI DELLA RICERCA

VIAPIANA, Ombretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.948
EU - Europa 14.377
AS - Asia 10.040
SA - Sud America 1.373
Continente sconosciuto - Info sul continente non disponibili 541
AF - Africa 317
OC - Oceania 23
Totale 42.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.563
RU - Federazione Russa 5.144
SG - Singapore 3.935
GB - Regno Unito 3.038
CN - Cina 2.931
IT - Italia 2.153
BR - Brasile 1.067
DE - Germania 918
VN - Vietnam 869
HK - Hong Kong 816
SE - Svezia 718
FR - Francia 682
IE - Irlanda 605
FI - Finlandia 422
BD - Bangladesh 305
KR - Corea 288
IN - India 217
CA - Canada 202
JP - Giappone 156
UA - Ucraina 156
TR - Turchia 134
AR - Argentina 108
PL - Polonia 94
MX - Messico 92
NL - Olanda 92
ES - Italia 75
NG - Nigeria 75
ID - Indonesia 72
ZA - Sudafrica 66
IQ - Iraq 57
AT - Austria 54
BE - Belgio 50
EC - Ecuador 49
VE - Venezuela 39
CO - Colombia 38
BJ - Benin 36
PK - Pakistan 31
UZ - Uzbekistan 31
CL - Cile 27
RO - Romania 24
MA - Marocco 22
SA - Arabia Saudita 22
EG - Egitto 21
TG - Togo 21
CH - Svizzera 20
IR - Iran 19
LT - Lituania 19
KE - Kenya 18
PE - Perù 18
AU - Australia 17
CR - Costa Rica 17
JM - Giamaica 17
AE - Emirati Arabi Uniti 16
MY - Malesia 16
IL - Israele 15
PH - Filippine 15
AZ - Azerbaigian 12
PY - Paraguay 12
NP - Nepal 11
CZ - Repubblica Ceca 10
DZ - Algeria 10
GR - Grecia 10
AL - Albania 9
BG - Bulgaria 9
HN - Honduras 9
HR - Croazia 9
TN - Tunisia 9
DK - Danimarca 8
JO - Giordania 8
PT - Portogallo 8
BO - Bolivia 7
EE - Estonia 7
ET - Etiopia 7
LB - Libano 7
SN - Senegal 7
TH - Thailandia 7
AM - Armenia 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HU - Ungheria 6
PA - Panama 6
PR - Porto Rico 6
QA - Qatar 6
SV - El Salvador 6
UY - Uruguay 6
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BH - Bahrain 4
CI - Costa d'Avorio 4
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
LY - Libia 4
NI - Nicaragua 4
NO - Norvegia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
Totale 42.015
Salva come PNG Salva come JPEG
Città #
Southend 2.632
Singapore 2.097
Ashburn 1.979
Moscow 1.754
San Jose 1.675
Dallas 1.341
Chandler 1.335
Jacksonville 887
Hong Kong 800
Council Bluffs 640
Dublin 601
Beijing 507
Verona 493
Ann Arbor 475
Woodbridge 465
The Dalles 386
New York 356
Houston 321
Los Angeles 314
Ho Chi Minh City 270
Wilmington 236
Lawrence 235
Princeton 234
Jinan 224
Bologna 195
Redmond 194
Hanoi 186
Nanjing 173
Shenyang 173
Santa Clara 161
Milan 152
Munich 143
Tokyo 138
Buffalo 137
Helsinki 136
São Paulo 115
Tianjin 105
Hebei 104
Redondo Beach 102
Sindelfingen 85
Rome 82
Warsaw 80
London 77
Orem 76
Changsha 75
Zhengzhou 73
Abuja 72
Columbus 68
Ningbo 68
Haikou 67
Denver 65
Phoenix 62
Chicago 59
Brooklyn 58
Nanchang 58
Taizhou 58
Montreal 56
Guangzhou 55
Toronto 55
Hangzhou 54
Redwood City 54
San Francisco 53
Seattle 52
Atlanta 50
Falkenstein 50
Jiaxing 49
Brussels 45
Turku 45
Da Nang 44
Taiyuan 44
Washington 44
Boardman 39
Johannesburg 39
Boston 38
Hyderabad 38
Naples 38
Manchester 37
Mexico City 37
Cotonou 36
Norwalk 36
Poplar 36
Chennai 34
Frankfurt am Main 34
Stockholm 33
Vienna 33
Rio de Janeiro 32
Brasília 31
Fuzhou 30
Tashkent 29
Amsterdam 28
Jakarta 28
Düsseldorf 27
Fairfield 27
Haiphong 27
Lanzhou 26
McKinney 26
Dong Ket 25
Las Vegas 25
Mumbai 24
Falls Church 23
Totale 25.320
Salva come PNG Salva come JPEG
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 759
Teriparatide and denosumab combination therapy and skeletal metabolism 358
Artrite Reumatoide e Metabolismo Minerale 280
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 278
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 273
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 266
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 263
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 253
Anti-CCP antibodies and bone 250
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 246
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 240
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 236
Bone metabolism in patients with anorexia nervosa and amenorrhoea 236
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 234
[Risk factors for hip fracture in elderly persons]. 230
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 224
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 221
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 221
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 220
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 216
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 215
[Pathophysiology of osteoarthritis: perspectives] 215
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 215
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 215
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 213
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 212
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 212
Bone involvement and osteoporosis in mastocytosis. 210
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 210
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 209
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 205
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 205
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 202
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 198
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 198
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 197
Prevalence and incidence of rheumatoid arthritis in Italy. 196
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 195
Could γ\δ T-cells explain zoledronic acid adverse events? 194
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 193
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 191
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 190
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 190
Guidelines for the diagnosis, prevention and management of osteoporosis 189
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 189
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 188
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 188
Allergy and the bone: unexpected relationships 186
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 186
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 186
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 186
Osteopetrosi 184
The obesity paradox and osteoporosis 184
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 183
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 182
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 181
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 179
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 179
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 178
Bone Disease in Mastocytosis 178
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 177
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 176
DXA bone mineral density in males: retrospective study in real life. 175
Sclerostin and DKK1 in primary hyperparathyroidism. 175
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 175
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 174
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 174
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 174
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 172
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 172
Association between environmental air pollution and rheumatoid arthritis flares 172
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 171
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 170
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 170
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 169
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 168
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 168
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 168
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 167
Invecchiamento dell'apparato scheletrico 167
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 167
Effects of denosumab on peripheral lymphocyte subpopulations 167
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 166
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 164
Artropatie degenerative 164
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 164
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 164
Safety issues and adverse reactions with osteoporosis management 163
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 163
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 163
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 163
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 162
Prevalence of osteoporosis in patients affected by mastocytosis 161
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 161
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 159
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 158
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 158
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 157
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 157
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 156
Totale 19.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.933
article - articoli 141.843
book - libri 0
conference - conferenze 705
curatela - curatele 0
other - altro 1.575
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.810
Totale 295.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.232 0 0 0 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/20255.346 286 344 259 800 248 166 220 210 789 419 529 1.076
2025/202618.007 1.202 888 1.302 3.039 4.525 1.189 1.646 977 1.267 898 380 694
2026/20272.360 301 505 688 866 0 0 0 0 0 0 0 0
Totale 42.619